Solventum (NYSE:SOLV) Trading Up 7.5% – Here’s Why

Solventum Corporation (NYSE:SOLV) was up 7.5% during mid-day trading on Tuesday . The company traded as high as $87.21 and last traded at $86.4990. 535,453 shares changed hands during mid-day trading, a decline of 62% from the average daily volume of 1,396,965 shares. The stock had previously closed at $80.47.

Analysts Set New Price Targets

Several research firms recently issued reports on SOLV. BMO Capital Markets assumed coverage on Solventum in a report on Wednesday, July 8th. They issued a “market perform” rating and a $81.00 price objective on the stock. Weiss Ratings raised shares of Solventum from a “hold (c)” rating to a “hold (c+)” rating in a research note on Friday, July 17th. UBS Group raised shares of Solventum from a “neutral” rating to a “buy” rating and set a $95.00 target price on the stock in a research note on Tuesday. Wells Fargo & Company dropped their price target on shares of Solventum from $83.00 to $70.00 and set an “equal weight” rating for the company in a research note on Wednesday, May 6th. Finally, Stifel Nicolaus lowered their target price on Solventum from $105.00 to $90.00 and set a “buy” rating for the company in a research note on Wednesday, May 6th. Seven investment analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average target price of $86.00.

Solventum Price Performance

The company has a quick ratio of 0.75, a current ratio of 1.07 and a debt-to-equity ratio of 0.96. The stock has a fifty day moving average of $78.03 and a 200-day moving average of $74.19. The stock has a market capitalization of $15.34 billion, a price-to-earnings ratio of 10.85, a P/E/G ratio of 1.33 and a beta of 0.66.

Solventum (NYSE:SOLV) last announced its quarterly earnings results on Tuesday, May 5th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.35 by $0.13. Solventum had a net margin of 17.33% and a return on equity of 23.51%. The firm had revenue of $2.01 billion for the quarter, compared to analyst estimates of $1.97 billion. During the same period last year, the business earned $1.34 EPS. Solventum’s revenue for the quarter was down 3.0% compared to the same quarter last year. Solventum has set its FY 2026 guidance at 6.600-6.600 EPS. On average, equities research analysts predict that Solventum Corporation will post 6.58 EPS for the current fiscal year.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of SOLV. United Services Automobile Association purchased a new stake in Solventum during the 1st quarter valued at approximately $239,000. Woodline Partners LP raised its position in Solventum by 40.7% during the 1st quarter. Woodline Partners LP now owns 11,677 shares of the company’s stock worth $888,000 after buying an additional 3,377 shares during the last quarter. Intech Investment Management LLC lifted its stake in shares of Solventum by 167.0% in the 1st quarter. Intech Investment Management LLC now owns 16,669 shares of the company’s stock worth $1,268,000 after acquiring an additional 10,425 shares during the period. First Trust Advisors LP increased its stake in shares of Solventum by 5.8% during the second quarter. First Trust Advisors LP now owns 257,727 shares of the company’s stock worth $19,546,000 after acquiring an additional 14,151 shares during the period. Finally, Marshall Wace LLP purchased a new position in Solventum during the second quarter worth about $766,000.

Solventum Company Profile

Solventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes.